Study on the Safety of Drug BAY2586116 and How it Works in Patients With Obstructive Sleep Apnea (a Sleep Disorder Caused by the Narrowing and Collapse of the Airway During Sleep) Including the Blood Level of the Drug and Effect of Its Doses and Routes of Administration
Clinical trial NCT04236440 · COMPLETED
Trial details
- NCT number
- NCT04236440
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2021-05-06
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.